Maravai Lifesciences Holdings (MRVI) Stock Statistics & Valuation Metrics

Maravai Lifesciences Holdings has a market cap or net worth of $595.90M. The enterprise value is $1.10B.

Maravai Lifesciences Holdings has 143,975,430 shares outstanding. The number of shares has decreased by -2.65% in one year.

Maravai Lifesciences Holdings’s return on equity (ROE) is -0.45 and return on invested capital (ROIC) is -24.43%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Maravai Lifesciences Holdings had revenue of 259.19M and earned -144.85M in profits. Earnings per share was -1.05.

In the last 12 months, operating cash flow was 9.24M and capital expenditures -4.76M, giving a free cash flow of 4.49M billion.

Maravai Lifesciences Holdings pays an annual dividend of ―, resulting in a dividend yield of ―

Maravai Lifesciences Holdings upcoming earnings date is Aug 11, 2025, After Close (Confirmed).

Maravai Lifesciences Holdings as a current ratio of 7.53, with Debt / Equity ratio of 12.36%

In the past 12 months, Maravai Lifesciences Holdings has paid -1.86M in taxes.

Maravai Lifesciences Holdings EV to EBITDA ratio is -5.14, with an EV/FCF ratio of -36.31.

Maravai Lifesciences Holdings has $285.05M in cash and marketable securities with $370.62M in debt, giving a net cash position of $85.57M billion.

Gross margin is 37.29%, with operating margin of -90.91%, and net profit margin of -55.89%.

The average price target for Maravai Lifesciences Holdings is $4.60, which is 11.43% higher than the current price. The consensus rating is Moderate Buy